Clinical Trials Logo

Frontal Fibrosing Alopecia clinical trials

View clinical trials related to Frontal Fibrosing Alopecia.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06202560 Enrolling by invitation - Clinical trials for Frontal Fibrosing Alopecia

Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study

Tofacitinib
Start date: November 29, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to study the efficacy and safety of Tofacitinib therapy in Thai patients with recalcitrant frontal fibrosing alopecia. The main questions are 1. Does Tofacitinib significantly reduce Frontal Fibrosing Alopecia Severity Index (FFASI), Frontal Fibrosing Alopecia Severity Score (FFASS), Lichen planopillaris Activity Index (LPPAI) compared to baseline and after 16 weeks? 2. Is Tofacitinib significantly different for adverse events compared to baseline and after 16 weeks? Participants will have a check-up in clinical and investigation and then get prescribed oral Tofacitinib 5 mg twice a day for 12 weeks. After that, they will have follow-up every 4 weeks until week 16.